I am not sure why some of you guys can be so bullish on gtg....

I am not sure why some of you guys can be so bullish on gtg. Sure, its a great test but the price of surviving Merv, Ironridge and getting the running out of cash boggie off its back its now got 1.75Billion shares on issue. Even at 100,000 tests p.a ( ie 50% of the new breast cancer patients in the US) remembering they only get tested once in a lifetime, is revenue of 50m at $500 a test less cogs, selling ,marketing and overhead which is 50% at Myriad ( so likely to be higher at gtg due to smaller scale), that's $25m, knock off tax and put a PE of 15( its just a one shot pony) and you get $262.5m, that's 15c a share, but its in 7 years. PV at 15% and you get 5.4c now. So if everything pans out fantastically well its worth 5.4c now. Buyers at 3.3c are effectively betting that Brevagen has about a 60% chance of getting used by 50% of the women who get breast cancer a year. I am not taking that bet.